This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Induced by Vincristine Therapy

Michael L. Shelanski, MD, PhD; Henryk Winiewski, MD, PhD

Arch Neurol. 1969;20(2):199-206.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

VINCRISTINE sulfate and vinblastine sulfate are dimeric alkaloids isolated from the periwinkle plant, Vinca rosea. Both of these agents have proven useful in inducing remission in leukemia, either alone or in concert with other agents. Their use, however, is often accompanied by evidence of nerve and muscle damage. The most common findings are dysesthesias,¹ anesthesia, and parasthesias in the fingers and toes,² loss of deep tendon reflexes in the lower extremities, weakness of extensors, foot drop, and ataxia.^3,4 In some cases this neuropathy has been reported to be reversible,² while in others no reversibility has been evident.³ Moress and his co-workers¹ have recently reported three cases in which severe and irreversible neuropathy was associated with vincristine therapy. A varying degree of axonal degeneration and myelin loss was seen in the peripheral nerves of these patients. The development of spheromembranous bodies in the muscles . . . [Full Text PDF of this Article]

Author Affiliations
New York

From the Department of Pathology (Neuropathology), Albert Einstein College of Medicine, New York.

Footnotes
Submitted for publication Aug 5, 1968; accepted Sept 24.

Reprint requests to Laboratory of Neuropathology, Albert Einstein College of Medicine, New York 10461 (Dr. Shelanski).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?